secwatch.observer — SEC 8-K summary
======================================

Issuer:     International Stem Cell CORP (ISCO)
CIK:        0001355790
Form:       8-K
Filed at:   2022-01-14T23:59:59+00:00
Accession:  0001564590-22-001352
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

International Stem Cell issues $2.9M promissory note to CEO Andrey Semechkin for working capital
--------------------------------------------------------------------------------

- Unsecured, non-convertible note for $2,900,000 issued to CEO/Co-Chairman on Jan 13, 2022.
- Replaces prior $2,650,000 note plus additional $250,000 provided by Dr. Semechkin.
- Interest rate of 4.5% per annum; principal and accrued interest due March 15, 2022.
- Borrower may prepay without penalty at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1355790/000156459022001352/0001564590-22-001352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1355790/000156459022001352/isco-8k_20220113.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-001352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer